Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia
- 1 August 2016
- journal article
- research article
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 25 (8) , 777-783
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Mutations in Calmodulin Cause Ventricular Tachycardia and Sudden Cardiac DeathThe American Journal of Human Genetics, 2012
- Videoscopic Left Cardiac Sympathetic Denervation for Patients With Recurrent Ventricular Fibrillation/Malignant Ventricular Arrhythmia Syndromes Besides Congenital Long-QT SyndromeCirculation: Arrhythmia and Electrophysiology, 2012
- Familial Evaluation in Catecholaminergic Polymorphic Ventricular TachycardiaCirculation: Arrhythmia and Electrophysiology, 2012
- Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndromeClinical Research in Cardiology, 2012
- Cardiac Channel Molecular Autopsy: Insights From 173 Consecutive Cases of Autopsy-Negative Sudden Unexplained Death Referred for Postmortem Genetic TestingMayo Clinic Proceedings, 2012
- Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in humanHuman Molecular Genetics, 2012
- Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular TachycardiaJACC, 2011
- Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardiaHeart Rhythm, 2010
- Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humansNature Medicine, 2009
- Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular TachycardiaCirculation Research, 2007